FRANKLIN LAKES, N.J., May 19, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medicaltechnology company, announced today the publication of its 2010 Sustainability Report. The report reaffirms the commitment of BD's 29,000 dedicated associates worldwide to pursuing the Company's purpose, "Helping all people live healthy lives,"
"In 2010, we continued to observe the strong connections between global health challenges and global environmental issues – and the role that BD can play in making progress in both areas," said Edward J. Ludwig, Chairman and Chief Executive Officer. "We continue to make progress and believe that our sustainability strategy drives our creativity. It helps us to be more innovative with regard to our actions, products, services and collaborations, which in turn drive growth and operating excellence."
BD's commitment to helping to provide affordable, accessible medical technologies that help address fundamental healthcare needs has been embedded in BD's culture since the Company's founding in 1897. Today, BD also recognizes the importance of strong environmental performance, and aspires to be recognized as the most environmentally responsible company in its industry.
The 2010 Sustainability Report highlights BD's priorities and performance in areas including:
2010 Awards and Recognition highlights include:
BD's 2010 Sustainability Report is available online at www.bd.com/sustainability.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
Contact:Colleen T. White, Corporate Communications – 201-847-5369Monique Dolecki, Investor Relations – 201-847-5453
SOURCE BD (Becton, Dickinson and Company)
Subscribe to our Free Newsletters!
Cholestatic jaundice occurs when the flow of bile (chole) between the liver and small intestine is ...
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...View All